MALVERN, PENNSYLVANIA, and STAFFORD, UK, 13 September 2006 -- PuriCore plc (“PuriCore” or the “Company”) (London Stock Exchange: PURI), the developer of a novel, safe technology that mimics the human body’s natural anti-microbial, hypochlorous acid, today announces its inaugural interim results for the six months ended 30 June 2006. The Company successfully listed its shares on the London Stock Exchange in June 2006.
